Question Bank › Ahead of their own clock

Ahead of their own clock

Ahead of their own clock: a consequential milestone just moved earlier than the company's own prior timeline

Calls Tested
496
Answered YES
17
Hit Rate
3.4%
rare by design

iRhythm Technologies, Inc. (IRTC) — this company's answers

NO on the Q1 2022 call 2022-05-07 C+
The model's full reasoning — Q1 2022 call → NOWe need answer only YES or NO. Need analyze transcript. Question asks: Does management state that a consequential upcoming milestone is happening earlier/faster than company's own previously communicated timeline? Need identify if any milestone pulled forward, ahead of schedule, faster than expected, near-dated, consequential. Let's scan transcript. Management discusses Q1 results, reimbursement, Zio Watch, next-gen biosensor, international expansion. Need find any statement about milestone ahead of schedule. Possible candidates: - Zio monitor next-generation biosensor: "we are very pleased to announce that we have shipped the first batch of our next-generation biosensor, the Zio monitor for first patient use following regulatory clearance. This monitor will eventually replace Zio XT... Full-scale commercialization and conversion of this next-generation device is anticipated in 2023." Is this ahead of schedule? No comparison to prior timeline. It's a milestone achieved (shipped first batch) but no statement that it's earlier than planned. Also full-scale in 2023, within next year? But no acceleration mentioned. - International expansion: "we will be commencing market access initiatives in Germany, France, the Netherlands and Sweden in the coming months" - no comparison to prior timeline. Japan: "anticipate initiating reimbursement and regulatory pathways within next few months, commercial launch by first half of 2024" - no acceleration. - NGS reimbursement update: "They updated their payment rates... effective April 1. We are pleased with this most recent update... continues to demonstrate..." This is a positive development but not described as ahead of schedule. It's a rate change, not a milestone that was previously scheduled. - Zio Watch: "currently under 510(k) review by FDA and pending clearance." No timeline acceleration. - Q1 results: "came in ahead of expectations across the board" - financial results beat guidance, not operational milestone. - "We continue to make progress on reimbursement front... NGS... updated payment rates... effective April 1." No mention of earlier than expected. - "We were pleased with first quarter revenue performance growing 24%... improved operational discipline... resulting in improved gross margin and lower-than-anticipated spending." That's financial.

← Back to the full IRTC analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management state that a CONSEQUENTIAL upcoming milestone for the company is now happening EARLIER or FASTER than the company's OWN previously communicated or previously assumed timeline — that is, management compares progress against the schedule the company itself had set and reports that the schedule has moved in the company's favor, with the milestone now near at hand? Answer YES when management's own words convey, in whatever form fits the business, this ONE phenomenon: a specific, identifiable step that matters to the company's future size or earnings — such as a facility, plant, mine, store rollout, or capacity coming online; a product, program, or service launching or shipping; a ramp reaching its target level; a contract, integration, conversion, or expansion completing; a certification, approval, qualification, or start-up being reached; or a turnaround or build phase finishing — is described as running AHEAD OF SCHEDULE, arriving SOONER THAN PLANNED, being PULLED FORWARD, or progressing FASTER THAN THE COMPANY ITSELF EXPECTED, with the earlier timing presented as management's own current expectation grounded in real progress already made (work completed, stages passed, early output or activity already occurring). The milestone should be near-dated — expected to land within roughly the next year — and management should treat it as consequential to the company's trajectory rather than a minor operational detail. Answer NO if the only "ahead of expectations" language refers to reported financial results beating guidance or consensus, with no operational milestone moving earlier in time. NO if management merely reaffirms that something remains "on track" or "on schedule" without the timing improving. NO if the acceleration is hoped for, targeted, or conditional rather than management's stated current expectation backed by progress already made. NO if the milestone is trivial or routine for this company, or so distant that its arrival falls well beyond the coming year. NO if management is explaining delays, slippage, or a schedule that moved later, even alongside positive spin. NO if the earlier timing is suggested only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
TEL TE Connectivity Ltd. Q4 2023 2023-11-01 B
INGN Inogen, Inc. Q1 2023 2023-05-05 F
VRE Veris Residential, Inc. Q4 2022 2023-02-22 D
HLIO Helios Technologies, Inc. Q1 2022 2022-05-10 C
ADSE ADS-TEC Energy PLC Q4 2021 2022-04-28 D
ZENV Zenvia Inc. Q4 2021 2022-03-17 C+
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
WMB The Williams Companies, Inc. Q3 2021 2021-11-02 B
CLVT Clarivate Plc Q2 2021 2021-07-31 B+
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
T AT&T Inc. Q3 2018 2018-10-24 C+
JBT John Bean Technologies Corporation Q2 2018 2018-07-26 B
AOSL Alpha and Omega Semiconductor Limited Q2 2018 2018-02-07 B
BCE BCE Inc. Q2 2017 2017-08-05 B+
WYY WidePoint Corporation Q3 2016 2016-11-09 D
ARKR Ark Restaurants Corp. Q1 2016 2016-05-13 B
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A

How the model reasoned

HLIO · Q1 2022 → YESThe question is: Does management state that a CONSEQUENTIAL upcoming milestone for the company is now happening EARLIER or FASTER than the company's OWN previously communicated or previously assumed t...YES The transcript shows management explicitly stating they are "on track to achieve the milestone that we have accelerated by two years of reaching at least $1 billion in revenue by 2023." This is presented as management's current expectation based on progress already made, with the $1B revenue target now arriving two years earlier than 2025. The milestone is consequential to the company's future size and earnings trajectory, and it is near at hand (within the next year). This matches the criteria for an accelerated timeline driven by real operational progress. The answer is YES.
AGIO · Q3 2018 → YESThe question is: Does management state that a CONSEQUENTIAL upcoming milestone is now happening EARLIER or FASTER than the company's OWN previously communicated timeline? **YES** Management explicitly states that the sNDA submission for ivosidenib in newly diagnosed AML patients ineligible for standard therapies is now planned for the end of January 2019, following acceleration of the frontline strategy. This is presented as a direct result of FDA discussions and Real-Time Oncology Review participation, with the 34-patient cohort data already generated and accepted into the pilot program. The timing is framed as an improvement over prior expectations, making the milestone (submission of the application) imminent and consequential for expanding TIBSOVO access.
ESE · Q2 2016 → YESThe question is: Does management state that a CONSEQUENTIAL upcoming milestone is now happening EARLIER or FASTER than the company's OWN previously communicated timeline? YES The transcript shows management explicitly stating that the restructuring actions (a key cost-reduction milestone tied to future earnings and operational focus) are "running ahead of schedule" and "progressing ahead of schedule," with completion expected to eliminate management distraction and deliver anticipated benefits sooner than previously planned.

More from the question bank

Correcting the record with current factsReordering the pecking orderSomeone else already paid for the growthAlready spoken for downstreamScarcity premium: the thing the company sellPaid-in full, payoff just startingAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.